Correlation Between Teradyne and UNITEDHEALTH
Specify exactly 2 symbols:
By analyzing existing cross correlation between Teradyne and UNITEDHEALTH GROUP INC, you can compare the effects of market volatilities on Teradyne and UNITEDHEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teradyne with a short position of UNITEDHEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teradyne and UNITEDHEALTH.
Diversification Opportunities for Teradyne and UNITEDHEALTH
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Teradyne and UNITEDHEALTH is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Teradyne and UNITEDHEALTH GROUP INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UNITEDHEALTH GROUP INC and Teradyne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teradyne are associated (or correlated) with UNITEDHEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UNITEDHEALTH GROUP INC has no effect on the direction of Teradyne i.e., Teradyne and UNITEDHEALTH go up and down completely randomly.
Pair Corralation between Teradyne and UNITEDHEALTH
Considering the 90-day investment horizon Teradyne is expected to generate 9.18 times more return on investment than UNITEDHEALTH. However, Teradyne is 9.18 times more volatile than UNITEDHEALTH GROUP INC. It trades about 0.18 of its potential returns per unit of risk. UNITEDHEALTH GROUP INC is currently generating about -0.37 per unit of risk. If you would invest 11,689 in Teradyne on October 5, 2024 and sell it today you would earn a total of 903.00 from holding Teradyne or generate 7.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Teradyne vs. UNITEDHEALTH GROUP INC
Performance |
Timeline |
Teradyne |
UNITEDHEALTH GROUP INC |
Teradyne and UNITEDHEALTH Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Teradyne and UNITEDHEALTH
The main advantage of trading using opposite Teradyne and UNITEDHEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teradyne position performs unexpectedly, UNITEDHEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UNITEDHEALTH will offset losses from the drop in UNITEDHEALTH's long position.Teradyne vs. IPG Photonics | Teradyne vs. Ultra Clean Holdings | Teradyne vs. Onto Innovation | Teradyne vs. Cohu Inc |
UNITEDHEALTH vs. Universal Technical Institute | UNITEDHEALTH vs. Sunlands Technology Group | UNITEDHEALTH vs. High Performance Beverages | UNITEDHEALTH vs. Oatly Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data |